Rolf Hoffmann has been appointed as an Additional Director of Bayer CropScience Ltd. w.e.f June 01, 2019. He has been appointed as the Whole Time Director and Chief Financial Officer of the Company with effect from July 01, 2019, subject to the approval of shareholders and Central Government.The shareholders approved his appointment as on July 24, 2019.
Mr. Hoffmann joined Bayer AG as a commercial trainee in 1995. After completion of the traineeship in 1999, Mr. Hoffmann spend 1 year in marketing and sales for Bayer MaterialScience (Covestro), before he moved to Corporate Audit as an auditor. From 2004 to 2010, he was transferred to Asia Pacific to take over the role as Chief Financial Officer / Compliance Officer for the Bayer Group in Vietnam (Bayer Vietnam Ltd.) and subsequently as Chief Financial Officer in Korea (Bayer Korea Ltd.).
In 2010, Mr. Hoffmann was transferred back to Germany (Bayer AG) to lead the Corporate Planning and Forecasting team for the Group and later on as well the country platform controlling for country subsidiaries as additional responsibility. In 2014, Mr. Hoffmann was transferred back to Asia Pacific to head the Bayer Healthcare Controlling function as well as the Finance business partner team for the Pharmaceutical Division for Greater China, based in Beijing (Bayer Healthcare China Ltd.). From 2016 till May 2019 he was responsible for the regional finance role of the International EMEA region of the Consumer Health Division, out of Switzerland (Bayer Consumer Care AG). Mr. Hoffmann is a MBA from the University of Bradford, UK.